DK2701707T3 - Fremgangsmåde til behandling af dyskinesi - Google Patents
Fremgangsmåde til behandling af dyskinesi Download PDFInfo
- Publication number
- DK2701707T3 DK2701707T3 DK12777826.4T DK12777826T DK2701707T3 DK 2701707 T3 DK2701707 T3 DK 2701707T3 DK 12777826 T DK12777826 T DK 12777826T DK 2701707 T3 DK2701707 T3 DK 2701707T3
- Authority
- DK
- Denmark
- Prior art keywords
- dyskinesia
- procedure
- treatment
- Prior art date
Links
- 208000012661 Dyskinesia Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161480415P | 2011-04-29 | 2011-04-29 | |
PCT/US2012/035129 WO2012149113A1 (en) | 2011-04-29 | 2012-04-26 | Method of treating dyskinesia |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2701707T3 true DK2701707T3 (da) | 2020-11-02 |
Family
ID=47072743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12777826.4T DK2701707T3 (da) | 2011-04-29 | 2012-04-26 | Fremgangsmåde til behandling af dyskinesi |
Country Status (13)
Country | Link |
---|---|
US (1) | US9289423B2 (da) |
EP (1) | EP2701707B1 (da) |
CA (1) | CA2834735C (da) |
CY (1) | CY1123614T1 (da) |
DK (1) | DK2701707T3 (da) |
ES (1) | ES2829223T3 (da) |
HR (1) | HRP20201736T1 (da) |
HU (1) | HUE052542T2 (da) |
LT (1) | LT2701707T (da) |
PL (1) | PL2701707T3 (da) |
PT (1) | PT2701707T (da) |
SI (1) | SI2701707T1 (da) |
WO (1) | WO2012149113A1 (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10071088B2 (en) | 2012-06-26 | 2018-09-11 | Precondit, Llc | Anti-nausea drug combinations |
WO2015187932A1 (en) * | 2014-06-04 | 2015-12-10 | Mentinova Inc. | Compositions and methods of reducing sedation |
EP3183232B1 (en) | 2014-08-22 | 2023-05-03 | The Arizona Board of Regents on behalf of The University of Arizona | Substituted 1-arylethyl-4-acylaminopiperidine derivatives as opioid/alpha-adrenoreceptor modulators and method of their preparation |
EP3436013A4 (en) * | 2016-03-31 | 2019-11-13 | Versi Group, LLC | COMPOSITIONS BASED ON OPIACE RECEPTOR DELTA / OPAACEOUS RECEPTOR DELTA OPTIONAL AGONIST, AND METHODS FOR TREATING PARKINSON'S DISEASE |
WO2018123822A1 (ja) * | 2016-12-28 | 2018-07-05 | 久光製薬株式会社 | ブトルファノール含有貼付剤 |
US11186585B2 (en) | 2018-08-17 | 2021-11-30 | Kappa-Pharma LLC | Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates |
JP2023510341A (ja) * | 2020-01-10 | 2023-03-13 | トレビ セラピューティクス インコーポレイテッド | ナルブフィン投与メソッド |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0615756B1 (en) | 1993-03-15 | 2001-06-27 | National Science Council | Nalbuphine esters and long-acting pharmaceutical compositions containing them |
CN1049577C (zh) | 1994-02-28 | 2000-02-23 | 胡幼圃 | 那布扶林镇痛剂的长效前体药物及其制备方法 |
US5750534A (en) | 1994-03-16 | 1998-05-12 | National Science Council | Nalbuphine esters having long acting analgesic action and method of use |
AUPO274596A0 (en) * | 1996-10-04 | 1996-10-31 | Armstrong, Stuart Maxwell | Method for the treatment of neurological or neuropsychiatric disorders |
ATE233264T1 (de) | 2000-04-27 | 2003-03-15 | Oliver Yoa-Pu Hu | Polynalbuphinderivat |
JP2003535833A (ja) * | 2000-06-09 | 2003-12-02 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | ナルブフィンとオピオイドアンタゴニストを使用した疼痛の処置法 |
EP1309354A2 (en) | 2000-07-27 | 2003-05-14 | Rutgers, The State University | Therapeutic polyesters and polyamides |
US6569449B1 (en) | 2000-11-13 | 2003-05-27 | University Of Kentucky Research Foundation | Transdermal delivery of opioid antagonist prodrugs |
US6703398B2 (en) | 2001-11-26 | 2004-03-09 | Oliver Yoa-Pu Hu | Orally administered analgesic compositions containing nalbuphine |
US7582635B2 (en) * | 2002-12-24 | 2009-09-01 | Purdue Pharma, L.P. | Therapeutic agents useful for treating pain |
US7759358B2 (en) | 2003-07-23 | 2010-07-20 | Crooks Peter A | Oral bioavailable prodrugs |
US20050137141A1 (en) | 2003-10-24 | 2005-06-23 | John Hilfinger | Prodrug composition |
US8163701B2 (en) | 2005-08-19 | 2012-04-24 | Signature Therapeutics, Inc. | Prodrugs of active agents |
US8394812B2 (en) | 2005-08-24 | 2013-03-12 | Penwest Pharmaceuticals Co. | Sustained release formulations of nalbuphine |
EP1931315B1 (en) | 2005-08-24 | 2013-10-16 | Penwest Pharmaceuticals Co. | Sustained release formulations of nalbuphine |
EP2018178A4 (en) | 2006-04-25 | 2009-12-16 | Michael Victor Voronkov | ADMINISTRATION OF AN AGONIST-ANTAGONIST COMPLEX TO PATIENTS WITH OPIOID DEPENDENCE |
US20090186832A1 (en) | 2008-01-18 | 2009-07-23 | Shire Llc | Amino acid peptide pro-drugs of phenolic analgesics and uses thereof |
WO2010112942A1 (en) | 2009-04-02 | 2010-10-07 | Shire Llc | Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof |
EP2453900A1 (en) | 2009-07-17 | 2012-05-23 | Shire LLC | Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof |
WO2011083304A1 (en) | 2010-01-05 | 2011-07-14 | Shire Llc | Prodrugs of opioids and uses thereof |
TWI554271B (zh) * | 2010-12-28 | 2016-10-21 | 歐 賽提克股份有限公司 | 用於治療巴金森氏症的類鴉片激動劑與類鴉片拮抗劑之組合 |
-
2012
- 2012-04-26 PL PL12777826T patent/PL2701707T3/pl unknown
- 2012-04-26 SI SI201231848T patent/SI2701707T1/sl unknown
- 2012-04-26 US US14/113,340 patent/US9289423B2/en active Active
- 2012-04-26 ES ES12777826T patent/ES2829223T3/es active Active
- 2012-04-26 WO PCT/US2012/035129 patent/WO2012149113A1/en active Application Filing
- 2012-04-26 PT PT127778264T patent/PT2701707T/pt unknown
- 2012-04-26 CA CA2834735A patent/CA2834735C/en active Active
- 2012-04-26 DK DK12777826.4T patent/DK2701707T3/da active
- 2012-04-26 EP EP12777826.4A patent/EP2701707B1/en active Active
- 2012-04-26 LT LTEP12777826.4T patent/LT2701707T/lt unknown
- 2012-04-26 HU HUE12777826A patent/HUE052542T2/hu unknown
-
2020
- 2020-10-20 CY CY20201100989T patent/CY1123614T1/el unknown
- 2020-10-28 HR HRP20201736TT patent/HRP20201736T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
JP2014523404A (ja) | 2014-09-11 |
LT2701707T (lt) | 2021-01-25 |
JP6134703B2 (ja) | 2017-05-24 |
US9289423B2 (en) | 2016-03-22 |
HUE052542T2 (hu) | 2021-05-28 |
CA2834735A1 (en) | 2012-11-01 |
SI2701707T1 (sl) | 2021-02-26 |
ES2829223T3 (es) | 2021-05-31 |
PL2701707T3 (pl) | 2021-03-08 |
EP2701707A1 (en) | 2014-03-05 |
EP2701707A4 (en) | 2014-11-19 |
WO2012149113A1 (en) | 2012-11-01 |
EP2701707B1 (en) | 2020-09-02 |
CA2834735C (en) | 2021-06-01 |
HRP20201736T1 (hr) | 2021-03-19 |
PT2701707T (pt) | 2020-11-09 |
US20140221415A1 (en) | 2014-08-07 |
CY1123614T1 (el) | 2022-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3520805T3 (da) | Sammensætninger til behandling af myelofibrose | |
DK2718404T3 (da) | Fremgangsmåde til fremstilling af flydende carbonhydrider | |
DK2897620T3 (da) | Fremgangsmåde til behandling af cancer | |
DK2895156T3 (da) | Fremgangsmåde til fremstilling af terapeutiske nanopartikler | |
DK2709613T4 (da) | Fremgangsmåder til behandling af hcv | |
DK3225604T3 (da) | Fremgangsmåde til fremstilling af flerlagsruder | |
DK2785349T4 (da) | Kombinationsbehandling af cancer | |
DK2717941T3 (da) | Behandling af cancer | |
DK2852391T3 (da) | Systemer til behandling af lungeinfektioner | |
DK2701733T3 (da) | Forbindelser til behandling af neuropsykiatriske forstyrrelser | |
DK2785801T4 (da) | Fremgangsmåde til formindskelse af isdannelse på et underlag | |
DK3581199T3 (da) | Fremgangsmåder til behandling eller reduktion af ødematøs fibrosklerotisk pannikulitis | |
BR112014013850A2 (pt) | conjunto de prateleiras | |
DK3396980T3 (da) | Binaural kompressor til opnåelse af retningsanvisninger | |
DK2836460T3 (da) | Fremgangsmåde til fremstilling af graphen | |
DK2838907T3 (da) | Aminosteroider til behandlingen af en ptp1b-associeret sygdom | |
DK2906219T3 (da) | Orvepitant til behandling af kronisk pruritus | |
DK2701707T3 (da) | Fremgangsmåde til behandling af dyskinesi | |
DK2807170T3 (da) | Phragmalin-limonoider til behandlingen af seksuel dysfunktion | |
DK2705847T3 (da) | Sammensætning til behandling af psoriasis | |
DK2920151T3 (da) | Fremgangsmåde til fremstilling af carboxamider | |
DK3202769T3 (da) | Fremgangsmåde til oprensning af phosphaplatinforbindelser | |
DK2838850T3 (da) | Oprensning af titantetrachlorid | |
DK2809782T3 (da) | Forbedret fremgangsmåde til fremstilling af makrokugler | |
DK3536410T3 (da) | Fremgangsmåde til behandling af affaldsgenstande |